GlobalData on MSN
How new technologies could transform clinical trial execution
The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.
In this Q&A article with the Eye Care Network, Daniela Ferrara, MD, PhD, FASRS, FARVO, discusses the role of low- and ...
The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new ...
What’s the Difference Between Nontherapeutic and Therapeutic? Benefits of Nontherapeutic Clinical Trials Examples of Nontherapeutic Clinical Trials How to Find a Nontherapeutic Clinical Trial When you ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
What Are Clinical Trials for MASH? Clinical trials for MASH are research studies that evaluate potential new treatments for a form of liver disease called metabolic dysfunction-associated ...
Trial Evaluates Solution to Sample Tampering in Point-of-Care Urine Drug Testing The EvoClinical team is proud to ...
Cognivia to host live webinar demonstrating how AI-driven behavioral signals help anticipate and manage dropout risk.
A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease Strategies to bring clinical trials closer to patients gained ...
What’s been overlooked is that the FDA already has the power to fix this. Without new legislation, pilot programs, or years ...
Susan Vadaparampil, PhD, MPH, of Moffitt Cancer Center, concludes her conversation with The American Journal of Managed Care® at last month’s Institute for Value-Based Medicine ® event in Tampa, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results